Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Virus-drug Combination Shows Improved Effectiveness Against Brain Tumor Cells

October 7, 2015 9:57 am | by University of Florida | News | Comments

A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found. Read more...

Smoking Cessation Drug Proves Initially More Effective for Women

October 7, 2015 9:53 am | by Yale University | News | Comments

The most effective prescription drug used to quit smoking initially helps women more than men, according to a Yale School of Medicine study. The study, published Oct. 7 by the journal Nicotine and Tobacco Research, found that varenicline, marketed as Chantix, was more effective earlier in women, and equally effective in women and men after one year. Read more...


Snapshot Turns T-Cell Immunology on its Head

October 7, 2015 8:15 am | by Monash University | News | Comments

Individuals with type 1 diabetes are thought to have a reduced number of the peacekeeping cells. Read more...


At a Glance: U.S. Trade Pact with Pacific Rim Countries

October 7, 2015 8:00 am | by The Associated Press | News | Comments

A key source of controversy stemmed from drug companies' efforts to protect their patents. Read more...


Oncolytics Concludes Enrollment for Phase 2 Prostate Cancer Study

October 7, 2015 7:45 am | News | Comments

Approximately 40 response evaluable patients were enrolled in each arm. Read more...


FDA Approves Aristada for Treatment of Schizophrenia

October 7, 2015 7:30 am | News | Comments

Alkermes is preparing to launch ARISTADA immediately.


Tolerant Immune System Increases Cancer Risk

October 7, 2015 7:15 am | by German Cancer Research Center | News | Comments

The scientists do not yet know why immune tolerance has an effect on certain cancer risks. Read more...


American Placebo

October 7, 2015 7:00 am | by McGill University | News | Comments

A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage. Read more...


New Test Predicts Teens’ Future Risk of Heart Disease

October 6, 2015 12:18 pm | by UVA Health System | News | Comments

Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children’s Hospital pediatrician and his collaborators. Read more...


Predicting Change in the Alzheimer’s Brain

October 6, 2015 11:15 am | by MIT News Office | News | Comments

MIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease on brain anatomy. Read more...


Inspirion Receives FDA Approval for MorphaBond, an Opioid Analgesic

October 6, 2015 11:09 am | News | Comments

Inspirion Delivery Technologies LLC ("Inspirion") announced that the United States Food and Drug Administration (FDA) has approved MorphaBond (morphine sulfate) extended-release tablets, for oral use, CII. Read more...


3 Ways Viruses Have Changed Science for the Better

October 6, 2015 11:04 am | by University of California San Francisco | News | Comments

A virus is nature’s efficient little killer. It can invade a cell, take over its inner machinery, trick it into making more virus DNA and escape with a new posse of virus children (often killing the host in the process). Read more...


Researchers Identify New Gene Linked to Amyloid Beta Plaque Buildup in Alzheimer's Disease

October 6, 2015 10:53 am | by Indiana University | News | Comments

In a newly published study, a multi-institutional team led by scientists at the Indiana University School of Medicine have discovered an immune system gene associated with higher rates of amyloid plaque buildup in the brains of Alzheimer's patients and older adults at risk for the disease. Read more...


Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools

October 6, 2015 10:23 am | by Laura McKain, M.D., Medical Director, Pharmacovigilance; Tammy Jackson, Director, Preclarus Development, Clinical Innovation; Cindy Elko-Simms, M.D., Vice President, Pharmacovigilance, of PPD | Articles | Comments

Pharmaceutical companies must continuously monitor the safety of investigational products in development for adverse events that may be unexpected, occur at an increased frequency or severity, or result in an unexpected outcome. Ongoing safety signal detection leads to optimal patient protection and is essential to obtaining regulatory approval. Read more...


New Papers Discuss Details for Possible 'Exercise Pill'

October 6, 2015 8:30 am | by Ryan Bushey, Associate Editor | News | Comments

Test results are promising, but there is still a lot of work to be done to make this pill a reality. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.